169 related articles for article (PubMed ID: 18077485)
1. COBRA combination therapy in daily practice--getting back to the future.
Boers M
Rheumatology (Oxford); 2008 Jan; 47(1):1-2. PubMed ID: 18077485
[No Abstract] [Full Text] [Related]
2. Treatment, management, and monitoring of established rheumatoid arthritis.
Bingham CO; Miner MM
J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
[No Abstract] [Full Text] [Related]
3. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
4. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
van Tuyl LH; Lems WF; Voskuyl AE; Kerstens PJ; Garnero P; Dijkmans BA; Boers M
Ann Rheum Dis; 2008 Nov; 67(11):1574-7. PubMed ID: 18625629
[TBL] [Abstract][Full Text] [Related]
5. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
Rasch LA; van Tuyl LH; Lems WF; Boers M
Neuroimmunomodulation; 2015; 22(1-2):51-6. PubMed ID: 25227967
[TBL] [Abstract][Full Text] [Related]
6. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
Verschueren P; Esselens G; Westhovens R
Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
[TBL] [Abstract][Full Text] [Related]
7. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Dijkmans BA; Boers M
Ann Rheum Dis; 2007 Jul; 66(7):974-6. PubMed ID: 17392349
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide in Pakistani patients with rheumatoid arthritis: prospective study in daily rheumatology practice.
Ahmad NM; Farman S; Saeed MA; Hameed R; Umair M; Ghafoor E
Int J Rheum Dis; 2011 Feb; 14(1):48-54. PubMed ID: 21303481
[TBL] [Abstract][Full Text] [Related]
9. Is attenuated COBRA treatment strategy (COBRA-light) non-inferior or not non-inferior than original COBRA strategy?
Akar S; Tinazli M
Clin Exp Rheumatol; 2014; 32(6 Suppl 87):S-18. PubMed ID: 25327510
[No Abstract] [Full Text] [Related]
10. Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
J Rheumatol; 2009 Jul; 36(7):1380-6. PubMed ID: 19487259
[TBL] [Abstract][Full Text] [Related]
11. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
Rheumatology (Oxford); 2008 Oct; 47(10):1571-6. PubMed ID: 18710900
[TBL] [Abstract][Full Text] [Related]
12. Treatment of rheumatoid arthritis.
Stohl W; Arkfeld DG
N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
[No Abstract] [Full Text] [Related]
13. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
Yazici Y; Abramson SB
Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
[TBL] [Abstract][Full Text] [Related]
15. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.
Möttönen T; Hannonen P; Leirisalo-Repo M; Nissilä M; Kautiainen H; Korpela M; Laasonen L; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Ilva K; Yli-Kerttula U; Puolakka K; Järvinen P; Hakola M; Piirainen H; Ahonen J; Pälvimäki I; Forsberg S; Koota K; Friman C
Lancet; 1999 May; 353(9164):1568-73. PubMed ID: 10334255
[TBL] [Abstract][Full Text] [Related]
17. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.
Konijn NPC; van Tuyl LHD; Boers M; den Uyl D; Ter Wee MM; van der Wijden LKM; Bultink IEM; Kerstens PJSM; Voskuyl AE; van Schaardenburg D; Nurmohamed MT; Lems WF
Rheumatology (Oxford); 2017 Sep; 56(9):1586-1596. PubMed ID: 28859326
[TBL] [Abstract][Full Text] [Related]
18. Two is better than one? Combination therapy in rheumatoid arthritis.
Choy EH
Rheumatology (Oxford); 2004 Oct; 43(10):1205-7. PubMed ID: 15226519
[No Abstract] [Full Text] [Related]
19. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
[TBL] [Abstract][Full Text] [Related]
20. Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples.
Combe B; van Vollenhoven R
Ann Rheum Dis; 2013 Sep; 72(9):1433-5. PubMed ID: 23625979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
